S&P 500   3,132.52 (-0.11%)
DOW   27,881.72 (-0.10%)
QQQ   203.90 (-0.08%)
AAPL   268.48 (+0.58%)
FB   200.87 (-0.23%)
MSFT   151.13 (-0.15%)
GOOGL   1,342.89 (+-0.01%)
AMZN   1,739.21 (-0.59%)
CGC   20.09 (-5.64%)
NVDA   213.98 (+0.85%)
MU   47.46 (+2.17%)
BABA   200.45 (+0.86%)
GE   11.01 (+0.18%)
TSLA   348.84 (+2.74%)
T   38.06 (+0.05%)
AMD   39.44 (+1.31%)
ACB   2.52 (-3.82%)
F   9.07 (+0.67%)
PRI   135.27 (-0.06%)
NFLX   293.12 (-3.10%)
BAC   33.53 (+0.06%)
GILD   67.08 (+0.22%)
DIS   146.10 (-0.08%)
S&P 500   3,132.52 (-0.11%)
DOW   27,881.72 (-0.10%)
QQQ   203.90 (-0.08%)
AAPL   268.48 (+0.58%)
FB   200.87 (-0.23%)
MSFT   151.13 (-0.15%)
GOOGL   1,342.89 (+-0.01%)
AMZN   1,739.21 (-0.59%)
CGC   20.09 (-5.64%)
NVDA   213.98 (+0.85%)
MU   47.46 (+2.17%)
BABA   200.45 (+0.86%)
GE   11.01 (+0.18%)
TSLA   348.84 (+2.74%)
T   38.06 (+0.05%)
AMD   39.44 (+1.31%)
ACB   2.52 (-3.82%)
F   9.07 (+0.67%)
PRI   135.27 (-0.06%)
NFLX   293.12 (-3.10%)
BAC   33.53 (+0.06%)
GILD   67.08 (+0.22%)
DIS   146.10 (-0.08%)
S&P 500   3,132.52 (-0.11%)
DOW   27,881.72 (-0.10%)
QQQ   203.90 (-0.08%)
AAPL   268.48 (+0.58%)
FB   200.87 (-0.23%)
MSFT   151.13 (-0.15%)
GOOGL   1,342.89 (+-0.01%)
AMZN   1,739.21 (-0.59%)
CGC   20.09 (-5.64%)
NVDA   213.98 (+0.85%)
MU   47.46 (+2.17%)
BABA   200.45 (+0.86%)
GE   11.01 (+0.18%)
TSLA   348.84 (+2.74%)
T   38.06 (+0.05%)
AMD   39.44 (+1.31%)
ACB   2.52 (-3.82%)
F   9.07 (+0.67%)
PRI   135.27 (-0.06%)
NFLX   293.12 (-3.10%)
BAC   33.53 (+0.06%)
GILD   67.08 (+0.22%)
DIS   146.10 (-0.08%)
S&P 500   3,132.52 (-0.11%)
DOW   27,881.72 (-0.10%)
QQQ   203.90 (-0.08%)
AAPL   268.48 (+0.58%)
FB   200.87 (-0.23%)
MSFT   151.13 (-0.15%)
GOOGL   1,342.89 (+-0.01%)
AMZN   1,739.21 (-0.59%)
CGC   20.09 (-5.64%)
NVDA   213.98 (+0.85%)
MU   47.46 (+2.17%)
BABA   200.45 (+0.86%)
GE   11.01 (+0.18%)
TSLA   348.84 (+2.74%)
T   38.06 (+0.05%)
AMD   39.44 (+1.31%)
ACB   2.52 (-3.82%)
F   9.07 (+0.67%)
PRI   135.27 (-0.06%)
NFLX   293.12 (-3.10%)
BAC   33.53 (+0.06%)
GILD   67.08 (+0.22%)
DIS   146.10 (-0.08%)
Log in

NYSE:NTR - Nutrien Stock Price, Forecast & News

$46.36
-0.58 (-1.24 %)
(As of 12/10/2019 04:00 PM ET)
Today's Range
$46.28
Now: $46.36
$46.85
50-Day Range
$46.27
MA: $48.03
$49.77
52-Week Range
$43.96
Now: $46.36
$56.00
Volume1.01 million shs
Average Volume1.49 million shs
Market Capitalization$26.56 billion
P/E Ratio17.23
Dividend Yield3.83%
Beta0.89
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations. Read More…

Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
Phone306-933-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.64 billion
Cash Flow$5.29 per share
Book Value$39.87 per share

Profitability

Net Income$3.57 billion

Miscellaneous

Employees20,300
Market Cap$26.56 billion
Next Earnings Date2/5/2020 (Estimated)
OptionableOptionable

Receive NTR News and Ratings via Email

Sign-up to receive the latest news and ratings for NTR and its competitors with MarketBeat's FREE daily newsletter.


Nutrien (NYSE:NTR) Frequently Asked Questions

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien declared a quarterly dividend on Tuesday, July 30th. Shareholders of record on Monday, September 30th will be given a dividend of $0.45 per share on Thursday, October 17th. This represents a $1.80 annualized dividend and a yield of 3.88%. The ex-dividend date is Friday, September 27th. This is a boost from Nutrien's previous quarterly dividend of $0.43. View Nutrien's Dividend History.

How were Nutrien's earnings last quarter?

Nutrien Ltd (NYSE:NTR) issued its earnings results on Monday, November, 4th. The company reported $0.24 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.36 by $0.12. The firm earned $4.13 billion during the quarter, compared to analyst estimates of $4.02 billion. Nutrien had a net margin of 20.95% and a return on equity of 6.49%. Nutrien's revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.47 EPS. View Nutrien's Earnings History.

When is Nutrien's next earnings date?

Nutrien is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Nutrien.

What price target have analysts set for NTR?

15 brokers have issued 12-month price targets for Nutrien's stock. Their forecasts range from $50.00 to $70.00. On average, they anticipate Nutrien's share price to reach $60.53 in the next year. This suggests a possible upside of 30.6% from the stock's current price. View Analyst Price Targets for Nutrien.

What is the consensus analysts' recommendation for Nutrien?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 3 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

Has Nutrien been receiving favorable news coverage?

Media coverage about NTR stock has been trending somewhat positive on Tuesday, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nutrien earned a news impact score of 1.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Nutrien.

Are investors shorting Nutrien?

Nutrien saw a drop in short interest in October. As of October 31st, there was short interest totalling 3,960,000 shares, a drop of 17.7% from the September 30th total of 4,810,000 shares. Based on an average trading volume of 1,080,000 shares, the days-to-cover ratio is currently 3.7 days. Currently, 0.7% of the shares of the stock are short sold. View Nutrien's Current Options Chain.

Who are some of Nutrien's key competitors?

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Cimarex Energy (XEC), JPMorgan Chase & Co. (JPM), General Electric (GE), Micron Technology (MU), CVS Health (CVS), Verizon Communications (VZ), Cisco Systems (CSCO), Bank of America (BAC) and Wells Fargo & Co (WFC).

Who are Nutrien's key executives?

Nutrien's management team includes the folowing people:
  • Mr. Charles Victor Magro B.Sc. (Chem), MBA, Pres, CEO & Exec. Director (Age 49)
  • Mr. Frederick R. Thun, Sr. VP of Fin.
  • Mr. Michael J. Frank, Exec. VP & CEO of Retail (Age 55)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 49)

Who are Nutrien's major shareholders?

Nutrien's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Beutel Goodman & Co Ltd. (2.30%), CIBC Asset Management Inc (1.25%), Great West Life Assurance Co. Can (0.96%), Boston Partners (0.65%), Cambiar Investors LLC (0.48%) and Sumitomo Mitsui Trust Holdings Inc. (0.43%).

Which major investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Cambiar Investors LLC, Millennium Management LLC, Beutel Goodman & Co Ltd., Addenda Capital Inc., CWM LLC, QV Investors Inc. and Russell Investments Group Ltd..

Which major investors are buying Nutrien stock?

NTR stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., Ilmarinen Mutual Pension Insurance Co, TIAA FSB, Great West Life Assurance Co. Can, Alberta Investment Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, Parametric Portfolio Associates LLC and Man Group plc.

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $46.36.

How big of a company is Nutrien?

Nutrien has a market capitalization of $26.56 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

What is Nutrien's official website?

The official website for Nutrien is http://www.nutrien.com/.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]


MarketBeat Community Rating for Nutrien (NYSE NTR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  267 (Vote Outperform)
Underperform Votes:  239 (Vote Underperform)
Total Votes:  506
MarketBeat's community ratings are surveys of what our community members think about Nutrien and other stocks. Vote "Outperform" if you believe NTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Featured Article: Return on Investment (ROI)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel